Protein glycation - Between tissue aging and protection.

Area of Science:

• Biochemistry
• Pathology
• Gerontology

Background:

• Non-enzymatic formation of advanced glycation endproducts (AGEs) is linked to degenerative diseases.
• Chronic AGE accumulation in tissues, particularly the extracellular matrix, causes collagen crosslinking and tissue stiffening, contributing to hypertension and heart failure.
• Soluble AGEs binding to RAGE triggers inflammation, while soluble RAGE (sRAGE) offers protection against inflammatory injuries like arteriosclerosis.

Purpose of the Study:

• To explore the dual role of advanced glycation endproducts (AGEs) in biological systems.
• To investigate the potential protective effects of AGEs beyond their known association with disease.
• To understand the implications of protein glycation as a hormetic response.

Main Methods:

• Literature review and synthesis of existing research on AGE formation, RAGE signaling, and AGE effects.
• Analysis of studies investigating AGEs in the context of aging, cardiovascular disease, and cancer.
• Examination of evidence for protective roles of AGEs, including nutritional AGEs and glyoxal-induced modifications.

Main Results:

• AGE accumulation is a hallmark of aging and contributes to tissue stiffening and cardiovascular dysfunction.
• RAGE activation by AGEs promotes inflammatory responses, while sRAGE can mitigate these effects.
• Emerging evidence suggests AGEs may exert protective effects, such as inhibiting lung tumor growth and reducing ischemia-reperfusion injury.

Conclusions:

• Protein glycation, leading to AGE formation, acts as a double-edged sword.
• AGEs contribute to tissue aging and degenerative diseases.
• AGEs also exhibit protective effects, indicating a hormetic response where the same stressor can have beneficial or detrimental outcomes depending on dose and context.